期刊文献+

世界卫生组织国际药物警戒合作中心的简介与启示 被引量:2

Introduction to WHO Collaborating Centre for Pharmacovigilance
下载PDF
导出
摘要 目的了解世界卫生组织(WHO)国际药物警戒合作中心的相关情况,为我国设立药物警戒相关国际组织提供借鉴。方法通过文献研究法和比较分析法,简要介绍了WHO国际药物警戒合作中心的组建发展、工作任务和学术交流方式等内容。结果 WHO出台了系列政策规范并支持合作中心的官方地位,地方政府也积极给予合作中心经费上的帮助。WHO通过多种合作方式成立了多个国际药物警戒合作中心。这些合作中心通过多种形式的交流培训促进区域药物警戒工作的开展。结论借鉴国际做法,在国内沿海发达地区设立药物警戒相关国际性合作组织,以期提高我国在药物警戒领域的国际影响力,履行一定的国际义务,同时发挥对亚洲地区的带动和引领作用。 Objective To find out more about the WHO Collaborating Center for Pharmacovigilance so as to provide reference for the establishment of pharmacovigilance-related international organizations in China.Methods Based on literature study and comparative analysis,the WHO Collaborating Center for Pharmacovigilance was introduced in terms of founding,development missions and ways of academic exchange.Results The WHO has issued a series of policies and regulations to support the official status of this center,while local governments have also actively provided financial assistance to it.The WHO has established multiple international pharmacovigilance collaborating centers using a variety of collaborating methods.These collaborating centers promote regional pharmacovigilance in various forms of exchange or training.Conclusion It is recommended that China learn from international practices and set up pharmacovigilance-related international collaborating organizations in developed coastal areas in order to make China more influential in the field of pharmacovigilance,fulfill international obligations,and play a leading role in Asia.
作者 魏芬芳 毛秋荣 成斌 钟翎 WEI Fenfang;MAO Qiurong;CHENG Bin;ZHONG Ling(Shenzhen Institute of Pharmacovigilance and Risk Management,Shenzhen Guangdong 518000,China)
出处 《中国药物警戒》 2020年第9期567-571,共5页 Chinese Journal of Pharmacovigilance
基金 2019年广东省药品不良反应监测中心委托项目“粤港澳大湾区药物警戒模式研究”。
关键词 国际药物警戒合作中心 药品评价 药品安全 国际交流 WHO Collaborating Centre for Pharmacovigilance drug evaluation drug safety international exchange
  • 相关文献

参考文献3

二级参考文献11

  • 1[1]Edwards I R,Biriell C.Harmonisation in pharmacovigilance[J].Drug Safety,1994,10:93-102. 被引量:1
  • 2[2]Bégaud B,Evreux J C,Jouglard J,et al.Unexpected or toxic drug reaction assessment (imputation).Actualisation of the method used in France[J].Thérapie,1985,40:111-118. 被引量:1
  • 3[3]Meyboom R H B,Hekster Y A,Egberts A C G,et al.Causal or casual? The role of causality assessment in pharmacovigilance[J].Drug Safety,1997,16:374-389. 被引量:1
  • 4[4]Meyboom R H B,Egberts A C G,Edwards I R,et al.Principles of signal detection in pharmacovigilance[J].Drug Safety,1997,16:355-365. 被引量:1
  • 5Edwards IR. Spontaneous reporting-of what? Clinical concerns about drugs [J]. Br J Clin Pharmacol,1999,48:138-141. 被引量:1
  • 6Aronson JK, Hauben M. Anecdotes that provide definitive evidence [ J ]. BMJ, 2006,333 : 1267 -9. 被引量:1
  • 7Noren GN, Sundberg R, Bate A, et al. A statistical methodology for drugdrug interaction surveillance[J]. Stat Med,2008,27:3057-3070. 被引量:1
  • 8Nor6n GN, Orre R, Bate A, et ,al. Duplicate detection in adverse drug reaction surveillance [ J ]. Data Min Knowl Disc,2007,14:305 -328. 被引量:1
  • 9WHO Collaborating Centre for International Drug Monitoring, Uppsala[EB/ OL]. http://who-umc. org/DynPage, aspx 98102&mn17347&mn27252& mn 37254&ran47337. 被引量:1
  • 10Wood L, Martinez C. The general practice research database: role in pharmacovigilance[J]. Drug Safe, 2004,27:871-881. 被引量:1

共引文献18

同被引文献19

引证文献2

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部